The simplicity of the protocol is appealing, but the daily commitment and fasting requirement make it more demanding than a once-weekly injection
Tirzepatide is a dual GIP and GLP-1 receptor agonist, targeting two incretin pathways simultaneously
Because the shot is fast and performed by trained staff, many patients find that the convenience outweighs any temporary discomfort
However, it should not be taken unnecessarily or in high doses, as long-term excess may lead to side effects
[DOI] [PubMed] [Google Scholar] 297.Iba T., Nagaoka I., Boulat M
Each SLU-PP-332 tablet contains 500 MCG of the research compound, with 100 tablets per bottle